# A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants

> **NCT05431153** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Single dose of PF-07104091 as Tablet Formulation A (Treatment A)
- **DRUG:** Single dose of PF-07104091 as Tablet Formulation B (Treatment B)
- **DRUG:** Single dose of PF-07104091 as Tablet Formulation C (Treatment C)
- **DRUG:** Single dose of PF-07104091 as Tablet Formulation D (Treatment D)
- **DRUG:** Single dose of PF-07104091 as Tablet Formulation C (Treatment E)

## Key facts

- **NCT ID:** NCT05431153
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-10
- **Primary completion:** 2022-10-17
- **Final completion:** 2022-10-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05431153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05431153, "A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05431153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*